Aim: To evaluate the clinical history of a series of patients with Zollinger-Ellison syndrome
(ZES) in the period 1966 to 2002, before and after the introduction of the current …

One hundred forty‐four consecutive patients with Zollinger‐Ellison syndrome (ZES) were
reviewed at Bichat Hospital in 1985. The population included 117 patients with a …

Objectives: To address the value of surgery in patients with sporadic Zollinger-Ellison
syndrome (ZES) with negative imaging studies. Background: Medical control of acid …

Objective To determine the role of surgery in patients with Zollinger-Ellison syndrome (ZES)
and multiple endocrine neoplasia type 1 (MEN1) with either limited or advanced pancreatic …

With the development of effective drugs to control the gastric acid hypersecretion in Zollinger-
Ellison syndrome (ZES) patients, the role of surgery has changed. In 1982, Brennan …

The treatment of patients with Zollinger-Ellison syndrome (ZES) has undergone dramatic
evolution during the past decade. Although initially regarded as an incurable tumor …

About 30% of patients with MEN1 develop a Zollinger-Ellison syndrome. Meanwhile it is well
established that the causative gastrinomas are almost exclusively localized in the …

Reports of Cushing's syndrome in patients with the Zollinger–Ellison syndrome are rare,
although up to 30 percent of gastrinomas contain ACTH-like immunoreactivity. We …

BACKGROUND: Gastric carcinoid tumors occur in 15% to 50% of patients with multiple
endocrine neoplasia–1/Zollinger-Ellison syndrome (MEN-1/ZES) but are thought to be …

Background/Aims: It is unclear whether tumor location, size, or the presence of multiple
endocrine neoplasia type 1 (MEN-1) alters metastatic rate and survival in patients with …